Peter Huang

Company: Zentalis Pharmaceuticals

Job title: Senior Vice President Discovery

Seminars:

Discovery & Progress of ZN-c3, a Highly Potent & Selective WEE1 Inhibitor Undergoing Evaluation in Clinical Trials for the Treatment of Cancer 12:00 pm

Discovery of ZN-c3 as a potent and selective Wee1 inhibitor Exploring ZN-c3 antitumor effect as a single agent and in combination Diving into recent ZN-c3 clinical dataRead more

day: Day One